ArticleFrontiers in oncology2022

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis.

Si-Yue Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.